Stay updated on SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3. No visible changes to study data or page structure were observed.
    Difference
    0.0%
    Check dated 2026-03-07T13:15:15.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2; no visible changes to content or features.
    Difference
    0.0%
    Check dated 2026-02-13T16:37:57.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. This appears to be a behind-the-scenes version update with no visible changes to core content or functionality.
    Difference
    0.0%
    Check dated 2026-02-06T11:15:56.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    UI/metadata updates include a glossary toggle (show/hide), a No FEAR Act Data text update, and a new revision tag (v3.4.0). These are minor changes that do not affect trial data or core page content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-23T04:25:18.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision note updated from v3.3.3 to v3.3.4; no visible changes to core content or user-facing functionality on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T01:28:53.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Footer updated to Revision: v3.3.3. The HHS Vulnerability Disclosure entry and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-24T15:37:50.000Z thumbnail image

Stay in the know with updates to SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page.